SCHEMBL980310

SCHEMBL980310

COc1cccc2cc(C(=O)O)c(=O)oc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 1.00
CA1 P00915 1/20 1.00
CA2 P00918 1/20 1.00
CA3 P07451 1/20 1.00
CA4 P22748 1/20 1.00
CA6 P23280 1/20 1.00
CA5A P35218 1/20 1.00
CA7 P43166 1/20 1.00
CA9 Q16790 1/20 1.00
CA14 Q9ULX7 1/20 1.00
CA5B Q9Y2D0 1/20 1.00
HSD17B10 Q99714 2/20 0.73
POLB P06746 2/20 0.72
KMT2A Q03164 4/20 0.67
MEN1 O00255 3/20 0.67
GPR35 Q9HC97 2/20 0.66
MAOA P21397 1/20 0.66
HPGD P15428 4/20 0.65
ALDH1A1 P00352 4/20 0.65
SMN1; SMN2 Q16637 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11339314 0.99 CA12 (0.97) CA12CA1CA2CA3CA4
SCHEMBL7519005 0.88 CA12 (0.79) CA12CA1CA2CA3CA4
SCHEMBL11347549 0.87 CA12 (0.77) CA12CA1CA2CA3CA4
SCHEMBL11495843 0.87 CA12 (0.77) CA12CA1CA2CA3CA4
SCHEMBL11339310 0.87 CA12 (0.77) CA12CA1CA2CA3CA4
SCHEMBL28445182 0.87 CA12 (0.77) CA12CA1CA2CA3CA4
SCHEMBL2034208 0.86 CA12 (0.76) CA12CA1CA2CA3CA4
SCHEMBL22041596 0.85 CA12 (0.73) CA12CA1CA2CA3CA4
SCHEMBL28155268 0.85 CA12 (0.74) CA12CA1CA2CA3CA4
SCHEMBL981636 0.85 CA12 (0.73) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8968711-B2 Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process L'OREAL (FR) 2015-03-03 US claimed
CN-103965268-A Preparation method and application of 8-methoxycoumarin-3-glucose ester formate HEBEI CHINA TOBACCO INDUSTRY CO LTD 2014-08-06 CN claimed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US claimed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US claimed
US-4196128-A Process for the preparation of 3-cyanochromones WARNER-LAMBERT COMPANY (US) 1980-04-01 US claimed
CN-119192113-A Pleuromutilin derivative and preparation method and application thereof 西华大学 2024-12-27 CN disclosed
WO-2023204123-A1 COMPOUND, ACID GENERATOR COMPRISING SAID COMPOUND, PHOTORESIST, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE USING SAID PHOTORESIST サンアプロ株式会社 2023-10-26 WO disclosed
CN-111411137-B Method for synthesizing 8-methoxyl coumarin-3-carboxylic acid-6' -O-D-glucose ester on line under catalysis of lipase 浙江农林大学 2023-04-25 CN disclosed
CN-112939916-B Method for synthesizing coumarin-3-carboxylic acid compounds by one-pot two-step method 河南中烟工业有限责任公司 2022-08-19 CN disclosed
CN-110804045-B Coumarin hybrid pyridone amide derivative with potential anti-AD activity and preparation method and application thereof 浙江工业大学 2021-07-27 CN disclosed
CN-113024499-A Green synthesis method of coumarin-3-carboxylic acid compounds 河南中烟工业有限责任公司 2021-06-25 CN disclosed
CN-112939916-A Method for synthesizing coumarin-3-carboxylic acid compounds by one-pot two-step method 河南中烟工业有限责任公司 2021-06-11 CN disclosed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US disclosed
WO-2009089508-A1 ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-07-16 WO disclosed
US-20090028807-A1 COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION L'OREAL (FR) 2009-01-29 US disclosed
US-6355658-B1 COUMARIN ESTERS WITH ETHER GROUPS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2002-03-12 US disclosed
EP-0988298-A1 COUMARIN DERIVATIVES, METHODS OF PREPARATION AND APPLICATION AS MEDICINES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2000-03-29 EP disclosed
WO-1998055472-A1 COUMARIN DERIVATIVES, METHODS OF PREPARATION AND APPLICATION AS MEDICINES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1998-12-10 WO disclosed
US-4303664-A Novel penicillin derivatives containing a coumarin nucleus and medicines containing the same TEIJIN LIMITED (JP) 1981-12-01 US disclosed
US-4196128-A Process for the preparation of 3-cyanochromones WARNER-LAMBERT COMPANY (US) 1980-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS CUTA, SUCLG1, KRT18 CA12 15/4885CA1 185/4885CA2 214/4885
US-20090028807-A1 COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION CUTA, SYMPK, TPRKB CA12 3507/4885CA1 4550/4885CA2 3819/4885
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT ACMSD, CUTA, PCCA CA12 403/4885CA1 1334/4885CA2 712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.